New Nasal Spray Offers Life-Saving Alternative to EpiPen
For individuals with life-threatening allergies, there’s a new hope thanks to a groundbreaking FDA-approved alternative to the traditional EpiPen. This innovative nasal spray, known as Neffy, offers a potentially more convenient and less intimidating option amidst potentially dangerous reactions.
A Breath of Fresh Air for Allergy Sufferers
Before Neffy’s arrival, the EpiPen was the primary method for reversing severe allergic reactions known as anaphylaxis. However, data suggests that only half of EpiPen prescriptions were filled, potentially due to anxieties surrounding needle injections. This new intranasal spray aims to bridge that gap.
Huntsville Allergists Embrace Neffy
Dr. Joseph Forester, an allergist in Huntsville, reports that he has already begun prescribing Neffy to his patients. While he still writes more prescriptions for traditional EpiPens, he acknowledges the importance of having another treatment option available.
Overcoming Barriers to Treatment
“The concern has been that some people avoid administering their epinephrine when they need it, because of some needle phobia, or they’re afraid it might hurt,” Dr. Forester explains. “Delay in the use of epinephrine is known to be a risk factor for more severe reactions, so getting a treatment option that people will use when they should use it, well it’s nice to have options.”
Dr. Forester believes Neffy’s ease of use could encourage more people who need it to administer the crucial medication promptly.
A Convenient and Capable Option
Neffy is designed for individuals over 66 pounds and offers a number of potential advantages over the EpiPen, including a lower cost, longer shelf life, and improved portability. Its nasal spray format might also appeal to those who feel apprehensive about injections.
Expanding Access to Life-Saving Medication
The hope lies in Neffy’s ability to empower more people to confidently manage their allergies and potentially save lives. As Dr. Forester points out, “Whichever version a patient is prescribed, they should use when they need it, they’re both going to be effective. But you know, indications are that there are people who will preferably use an intranasal spray over a needle option.”
This new treatment, approved by the FDA in August, represents a significant step forward in allergy care, providing a much-needed alternative that could have life-altering consequences for those living with severe allergies.
